Inventor
FERTIG GEORG
DE36 patents
⚠️ This page may combine multiple inventors who share the name “FERTIG GEORG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
29 patentsUS9879085B2Jan 30, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE10 citations92
US9663580B2May 30, 2017
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE11 citations92
US9499625B2Nov 22, 2016
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE12 citations92
US9499624B2Nov 22, 2016
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE12 citations92
US9499626B2Nov 22, 2016
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE12 citations92
US7208491B2Apr 24, 2007
N-monoacylated o-phenylenediamines
HOFFMANN LA ROCHE19 citations92
US6790852B2Sep 14, 2004
2-(2,6-dichlorophenyl)-diarylimidazoles
HOFFMANN LA ROCHE19 citations92
US10287358B2May 14, 2019
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE3 citations84
US10077314B1Sep 18, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE5 citations84
US10072087B2Sep 11, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE5 citations84
US10030073B2Jul 24, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE5 citations84
US10023643B2Jul 17, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE5 citations84
US9988458B2Jun 5, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE6 citations84
US9624302B2Apr 18, 2017
Nucleic acids encoding antibodies against human CSF-1R
HOFFMANN LA ROCHE11 citations84
US9617342B2Apr 11, 2017
Nucleic acids encoding antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE11 citations84
US9309319B2Apr 12, 2016
Antibodies against human IL33R and uses thereof
HOFFMANN LA ROCHE8 citations83
US10287352B2May 14, 2019
Bispecific antibodies specific for PD1 and TIM3
HOFFMANN LA ROCHE10 citations82
US10718762B2Jul 21, 2020
Cellular based fret assay for the determination of simultaneous binding
HOFFMANN LA ROCHE5 citations73
US10336830B2Jul 2, 2019
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE3 citations73
US11130810B2Sep 28, 2021
Bispecific antibodies specific for PD1 and TIM3
HOFFMANN LA ROCHE4 citations71
US7396944B2Jul 8, 2008
Thiophene derivatives, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE3 citations62
US6946471B2Sep 20, 2005
2-(2,6-Dichlorophenyl)-Diarylimidazoles
HOFFMANN LA ROCHE2 citations62
US12391757B2Aug 19, 2025
Bispecific antibodies specific for PD1 and TIM3
HOFFMANN LA ROCHE0 citations61
US7638553B2Dec 29, 2009
Hydroxamates, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE0 citations51
US7501451B2Mar 10, 2009
Mono-acylated o-phenylendiamines derivatives
HOFFMANN LA ROCHE0 citations51
US7423060B2Sep 9, 2008
Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors
HOFFMANN LA ROCHE1 citations51
US7173060B2Feb 6, 2007
Oxime derivatives and their use as pharmaceutically active agents
HOFFMANN LA ROCHE0 citations51
US7071219B2Jul 4, 2006
Mono-acylated o-phenylendiamines derivatives
HOFFMANN LA ROCHE0 citations51
US7098247B2Aug 29, 2006
Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives
HOFFMANN LA ROCHE0 citations41